Genomate Health Uses AI for Clinical Decisions in Oncology

Genomate Health operates in the precision oncology market, offering AI-powered clinical decision support.

The company does not perform sequencing itself but builds upon existing molecular testing data. Its aim is to assist oncologists in interpreting complex genomic information to identify the most suitable treatments for individual patients.

Alina Luchian, Chief Marketing Officer at Genomate Health, described the company's market view and customer needs in an interview with CB Insights.

Genomate Health seeks to enhance cancer treatment accuracy by providing advanced data analysis tools for physicians.